PTC cut its full-year revenue and adjusted earnings forecasts on Wednesday amid increasing competition and fears over President Donald Trump's tariff policy, which could result in fewer takers for its ...

PTC Inc. (PTC) announced earnings for its first quarter that increased from last year and beat the Street estimates. The company's ...

Engineering and design software provider PTC (NASDAQ:PTC) reported Q4 CY2024 results beating Wall Street’s revenue ...

PTC beat estimated earnings by 24.0%, reporting an EPS of $1.1 versus an estimate of $0.89. Revenue was up $14.91 million from the same period last year. Last quarter the company beat on EPS by $0.09 ...

The earnings results for PTC PTC for Q1 were made public on Wednesday, February 5, 2025 at 04:01 PM. Here's a comprehensive overview of the announcement. PTC beat estimated earnings by 24.0%, ...

The S&P 500 Index ($SPX) (SPY) today is down -0.20%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.04%, and the ...

The S&P 500 Index ($SPX) (SPY) today is down -0.27%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.04%, and the ...

Nasdaq 100 E-Mini futures (NQH25) are trending down -0.91% this morning as disappointing results from Alphabet and Advanced ...

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...

Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...

UBS analysts downgraded Calumet Specialty Products Partners' stock, traded on (NASDAQ:CLMT), from Neutral to Sell, setting ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...